Le Lézard
Classified in: Health, Business
Subject: JVN

AllianceRx Walgreens Prime Begins Launch of its New Brand


ORLANDO, Fla., Oct. 2, 2017 /PRNewswire/ -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and mail services company formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially began the launch of its new brand, which included the unveiling of new signage at its headquarters in Orlando, Fla., as well as at a few other company-owned facilities across the country. This also formally introduces the new brand to patients, some of whom will begin to see the AllianceRx Walgreens Prime name and logo on prescriptions and correspondence.  Full consumer rollout, and all components of the company, are expected to be aligned to the new brand by the end of March 2018.

AllianceRx Walgreens Prime's CEO Joel Wright unveils the company's new brand at its headquarters in Orlando, Fla.

As part of forming the new company and as a next step, approximately 3,000 positions will transfer from Walgreens and Prime to AllianceRx Walgreens Prime by the end of the year.  The company is also in the final stages of hiring approximately 1,000 more pharmacists, pharmacy technicians, nurses and other support personnel. This growth would bring the combined workforce of AllianceRx Walgreens Prime to approximately 4,000 people across multiple locations in 10 states.

Joel Wright, AllianceRx Walgreens Prime's CEO and a former divisional vice president for Walgreens specialty solutions, led efforts to unite central specialty pharmacies and mail services businesses previously owned by Walgreens or Prime.

"I'm excited to share our company's brand ? and all that it stands for ? with our patients and clients," said Wright.  "While AllianceRx Walgreens Prime is a newly combined company with a new name, we are built from the brands and operational strengths of two leading companies with more than 130 years combined experience in the pharmacy industry."

"I'm proud of how our teams have come together to serve patients. Every day we are living our purpose of 'We provide hope and care for better tomorrows'. It certainly rings true as this year's devastating hurricane season brought out the best in us. I've seen my entire team rise to the challenge working night and day to deliver medicines to those who were in harm's way," said Wright. "Our patients' care truly is our top priority."

In addition to delivering market-leading customer service, AllianceRx Walgreens Prime has access to one of the largest limited distribution drug portfolios so patients with complex conditions, such as cancer and multiple sclerosis, get increased access to specialty drugs.

For more information about the company, visit www.alliancerxwp.com

About AllianceRx Walgreens Prime
AllianceRx Walgreens Prime delivers maintenance medicines and specialty medicines through its mail service and central specialty pharmacies. Formed in 2017 through a strategic alliance between Walgreens, one of the nation's largest chain drug stores, and Prime Therapeutics, a leading pharmacy benefit manager (PBM), the company offers tools and resources to help patients improve medication adherence, 24/7 pharmacy support for exceptional care. The company is headquartered in Orlando, Fla. and its pharmacies are accredited by several national pharmacy accreditation services. Visit www.alliancerxwp.com for more information.

Media Contact
Karen Lyons, AllianceRx Walgreens Prime | [email protected] | 612.777.5742

 

AllianceRx Walgreens Prime is a new company formed by Walgreens and Prime Therapeutics earlier this year that will provide central specialty pharmacy and home delivery of medicines.

SOURCE AllianceRx Walgreens Prime


These press releases may also interest you

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

at 16:20
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...

at 16:20
Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales...

at 16:16
A functional assessment of Bacillus subtilis PLSSC (SEBtilistm) demonstrated its antimicrobial activity and capability to offer health benefits through industrial processing and the digestion process, showing its value-add in functional foods,...

at 16:15
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...



News published on and distributed by: